Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01252472 · ClinicalTrials.gov registry record
Flomax Study for Floppy Iris Syndrome
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 36
- Enrollment target
NCT01252472 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 36 participants.
The verdict
NCT01252472 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
Some men who have a history of use of Tamsulosin (Flomax) are at risk for a condition called Intraoperative Floppy Iris Syndrome that can develop during otherwise routine cataract surgery. It is not fully understood why this condition develops or who is at risk for developing it. In this study the investigators will take pictures of the iris and iris blood vessels before cataract surgery. The investigators hope that the results of this study will provide a better understanding of how Intraoperative Floppy Iris Syndrome develops and give us a non-surgical way of figuring out who might develop this problem during surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01252472
The ClinicalTrials.gov registry entry for NCT01252472 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01252472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01252472 about?
NCT01252472 is a clinical study titled "Flomax Study for Floppy Iris Syndrome". Some men who have a history of use of Tamsulosin (Flomax) are at risk for a condition called Intraoperative Floppy Iris Syndrome that can develop during otherwise routine cataract surgery. It is not fully understood why this condition develops or who is at risk for developing it. In this study the i...
What is the current status of trial NCT01252472?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2010-06. Estimated completion is 2013-12.
Who is sponsoring clinical trial NCT01252472?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.